IGM Biosciences Inc. (IGMS)

Name: IGM Biosciences Inc. (IGMS) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: IGM Biosciences Inc. (IGMS)

Stock Card

$1.27

$0.00 (0.00%)

As on 15-Aug-2025 09:30EDT

Market cap

$77 Mln

Revenue (TTM)

$145 Mln

P/E Ratio

P/B Ratio

0.8

Div. Yield

0 %

IGM Biosciences (IGMS) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.27 High: 1.27

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.5 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-2
Debt to Equity

0
Book Value

$--
EPS

$-0.9
Face value

--
Shares outstanding

36,593,200

7 Years Aggregate

CFO

$-465.24 Mln

EBITDA

$-797.56 Mln

Net Profit

$-777.98 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
IGM Biosciences (IGMS)	-79.2	-6.6	11.4	-85.4	-63.8	-52.4	--
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 15-Aug-2025 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2024	2023	2022	2021	2020
IGM Biosciences (IGMS)	-26.3	-51.1	-42.0	-66.8	131.4
S&P Small-Cap 600	7.0	13.9	-17.4	25.3	9.6
BSE Sensex	8.1	18.7	4.4	22.0	15.8

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
IGM Biosciences (IGMS)	1.3	76.6	145.1	-53.4	-26.7	-71.6	--	0.8
TF Financial Corp (THRD)	5.4	242.8	0.1	-53.5	-138,120.8	-18.8	--	0.9

Shareholding Pattern

View Details

About IGM Biosciences (IGMS)

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc.... in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. As of August 14, 2025, IGM Biosciences, Inc. operates as a subsidiary of Concentra Biosciences, LLC. Read more

CEO, President & Director

Mr. Fred M. Schwarzer J.D.
CEO, President & Director

Mr. Fred M. Schwarzer J.D.
Headquarters

Mountain View, CA
Website

https://igmbio.com

FAQs for IGM Biosciences (IGMS)

What is the current share price of IGM Biosciences Inc (IGMS) Today?

The share price of IGM Biosciences Inc (IGMS) is $1.27 (NASDAQ) as of 15-Aug-2025 09:30 EDT. IGM Biosciences Inc (IGMS) has given a return of -63.77% in the last 3 years.

What is the current PB & PE ratio of IGM Biosciences Inc (IGMS)?

Since, TTM earnings of IGM Biosciences Inc (IGMS) is negative, P/E ratio is not available.
The P/B ratio of IGM Biosciences Inc (IGMS) is 0.76 times as on 15-Aug-2025, a 86 discount to its peers’ median range of 5.35 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2024	-1.89	7.68
2023	-2.02	2.45
2022	-3.51	-1.31
2021	-6.17	-2.80
2020	-34.40	-14.65

What is the 52 Week High and Low of IGM Biosciences Inc (IGMS)?

The 52-week high and low of IGM Biosciences Inc (IGMS) are Rs -- and Rs -- as of 30-Aug-2026.

What is the market cap of IGM Biosciences Inc (IGMS)?

IGM Biosciences Inc (IGMS) has a market capitalisation of $ 77 Mln as on 15-Aug-2025. As per SEBI classification, it is a Small Cap company.

Should I invest in IGM Biosciences Inc (IGMS)?

Before investing in IGM Biosciences Inc (IGMS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.